5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec.
about
5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@ast
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@en
type
label
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@ast
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@en
prefLabel
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@ast
5-alpha-reductase inhibitor th ...... w rate of less than 15 ml/sec.
@en
P2093
P2860
P1433
P1476
5-alpha-reductase inhibitor th ...... ow rate of less than 15 ml/sec
@en
P2093
Jengyuan Wu
Shangsen Lee
Wenhsu Lin
Yuhung Kuo
P2860
P304
P356
10.1371/JOURNAL.PONE.0175356
P407
P50
P577
2017-04-10T00:00:00Z